New pacemaker wire placement for people with tricuspid valve procedures
Part of Heart & circulation clinical trials.
This study is testing a new way to place a pacemaker wire that avoids going through the tricuspid valve, which is a common area for problems. It may help people who have had or are having valve procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You need to have had or be planning a procedure on your tricuspid valve (like repair or replacement).
- Your doctor has decided that the pacemaker wire should not cross the tricuspid valve.
- A CT scan shows that the vein used for the wire is suitable.
- You are planning to get a specific type of pacemaker (dual-chamber, single-chamber, or CRT).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to place a defibrillator lead in a vein on the heart's surface, avoiding the tricuspid valve. It may help people who need a defibrillator but have a leaky tricuspid valve that could worsen with standard lead placement.
This trial is testing a new type of pacemaker system. It may be an option for adults who need a single-chamber ventricular pacemaker and are generally in good health.
This study looks at how a new pacemaker or defibrillator lead may affect the tricuspid valve (the valve between the right upper and lower heart chambers). It helps doctors understand if the lead causes leakage (regurgitation) over time.
This study looks at how heart devices like pacemakers affect the tricuspid valve over time. It uses ultrasound to check valve function and see if the device causes any problems.
This study looks at how a new pacemaker or defibrillator (CIED) might affect the tricuspid valve and the right side of the heart. It aims to understand these changes over time.
This trial tests a way to place a pacemaker lead using a special ultrasound view through the esophagus (a transesophageal echocardiogram). The goal is to reduce the chance of developing a serious leak in the tricuspid valve caused by the pacemaker lead.
Hear when a new Cardiac Conduction Disorders Requiring Permanent Pacing in Patients With Prior or Planned Tricuspid Valve Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.